A newly discovered phenylethanoid glycoside from Stevia rebaudiana bertoni affects insulin secretion in rat INS-1 islet β cells

Molecules

Volumn 24, Issue 22, 2019, Pages

  He, Jing ^a   Zhu, Nai Liang ^a,b   Kong, Jing ^a   Peng, Ping ^a   Li, Lin Fu ^a   Wei, Xiao Lu ^c   Jiang, Yan Yan ^a   Zhang, Yan Ling ^a   Bian, Bao Lin ^c   She, Gai Mei ^a   Shi, Ren Bing ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

DS; Insulin secretion; Phenylethanoid glycoside; Stevia rebaudiana Bertoni; Structure

Indexed keywords

GLYCOSIDE; PLANT EXTRACT;

ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CHINA; DRUG EFFECT; INSULIN RELEASE; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS ISLET BETA CELL; RAT; STEVIA;

ANIMALS; CELLS, CULTURED; CHINA; GLYCOSIDES; INSULIN SECRETION; INSULIN-SECRETING CELLS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PLANT EXTRACTS; RATS; STEVIA;

EID: 85075418886     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules24224178     Document Type: Article

References (40)

1. Ferrazzano, G.F.; Cantile, T.; Alcidi, B.; Coda, M.; Ingenito, A.; Zarrelli, A.; Di Fabio, G.; Pollio, A. Is Stevia rebaudiana Bertoni a non cariogenic sweetener? A Review. Molecules 2015, 21, 38. [CrossRef] [PubMed]
2. Pol, J.; Hohnova, B.; Hyotylainen, T. Characterisation of Stevia rebaudiana by comprehensive two-dimensional liquid chromatography time-of-flight mass spectrometry. J. Chromatogr. A 2007, 1150, 85-92. [CrossRef] [PubMed]
3. Tateo, F.; Escobar Sanchez, M.L.; Bononi, M.; Lubian, E. Stevioside content of Stevia rebaudiana (Bertoni) Bertoni grown in East Paraguay. Ital. J. Food Sci. 1999, 11, 265-269.
4. Shivanna, N.; Naika, M.; Khanum, F.; Kaul, V.K. Antioxidant, anti-diabetic and renal protective properties of Stevia rebaudiana. J. Diabetes Complicat. 2013, 27, 103-113. [CrossRef] [PubMed]
5. Chan, P.; Tomlinson, B.; Chen, Y.J.; Liu, J.C.; Hsieh, M.H.; Cheng, J.T. A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Brit. J. Clin. Pharmacol. 2000, 50, 215-220. [CrossRef] [PubMed]
6. Kujur, R.S.; Singh, V.; Ram, M.; Yadava, H.N.; Singh, K.K.; Kumari, S.; Roy, B.K. Antidiabetic activity and phytochemical screening of crude extract of Stevia rebaudiana in alloxan-induced diabetic rats. Pharm. Res. 2010, 2, 258-263.
7. Suanarunsawat, T.; Klongpanichapak, S.; Rungseesantivanon, S.; Chaiyabutr, N. Glycemic effect of stevioside and Stevia rebaudiana in streptozotocin- induced diabetic rats. East. J. Med. 2004, 9, 51-56.
8. Curi, R.; Alvarez, M.; Bazotte, R.B.; Botion, L.M.; Godoy, J.L.; Bracht, A. Effect of Stevia rebaudiana on glucose tolerance in normal adult humans. Braz. J. Med. Boil. Res. 1986, 19, 771-774.
9. Soejarto, D.D.; Kinghorn, A.D.; Farnsworth, N.R. Potential sweetening agents of plant origin. III. Organoleptic evaluation of Stevia leaf herbarium samples for sweetness. J. Nat. Prod. 1982, 45, 590. [CrossRef]
10. Peng, P. Study on Preparation Technology and Quality Standard of Effective Parts of Stevia and Its Hypoglycemic Effect. Master's Thesis, Beijing University of Chinese Medicine, Beijing, China, 2012.
11. Zhu, N.L. The Drug System Characterization of stevia Based on Antidiabetic. Ph.D. Thesis, Beijing University of Chinese Medicine, Beijing, China, 2014.
12. Li, J.; Hua, J.; Shi, R. A new acylated quercetin glycoside from the leaves of Stevia rebaudiana Bertoni. Nat. Prod. Res. 2009, 23, 1378-1383. [CrossRef]
13. Martin, F.; Hay, A.E.; Corno, L.; Gupta, M.P.; Hostettmann, K. Iridoid glycosides from the stems of Pithecoctenium crucigerum (Bignoniaceae). Phytochemistry 2007, 68, 1307-1311. [CrossRef] [PubMed]
14. Georgiev, M.; Alipieva, K.; Orhan, I.; Abrashev, R.; Denev, P.; Angelova, M. Antioxidant and cholinesterases inhibitory activities of Verbascum xanthophoeniceum Griseb. and its phenylethanoid glycosides. Food Chem. 2011, 128, 100-105. [CrossRef] [PubMed]
15. Harput, U.S.; Genc, Y.; Saracoglu, I. Cytotoxic and antioxidative activities of Plantago lagopus L. and characterization of its bioactive compounds. Food Chem. Toxicol. 2012, 50, 1554-1559. [CrossRef] [PubMed]
16. Kim, J.K.; Lee, Y.S.; Kim, S.H.; Bae, Y.S.; Lim, S.S. Inhibition of aldose reductase by phenylethanoid glycoside isolated from the seeds of Paulownia coreana. Biol. Pharm. Bull. 2011, 34, 160-163. [CrossRef] [PubMed]
17. Yang, K.; Hashemi, Z.; Han, W.; Jin, A.; Yang, H.; Ozga, J.; Li, L.; Chan, C.B. Hydrolysis enhances bioavailability of proanthocyanidin-derived metabolites and improves beta-cell function in glucose intolerant rats. J. Nutr. Biochem. 2015, 26, 850-859. [CrossRef]
18. Yang, K.; Chan, C.B. Epicatechin potentiation of glucose-stimulated insulin secretion in INS-1 cells is not dependent on its antioxidant activity. Acta Pharmacol. Sin. 2018, 39, 893-902. [CrossRef]
19. Badolato, M.; Carullo, G.; Perri, M.; Cione, E.; Manetti, F.; Di Gioia, M.L.; Brizzi, A.; Caroleo, M.C.; Aiello, F. Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators. Future Med. Chem. 2017, 9, 1873-1885. [CrossRef]
20. Rayasam, G.V.; Tulasi, V.K.; Sundaram, S.; Singh, W.; Kant, R.; Davis, J.A.; Saini, K.S.; Ray, A. Identification of berberine as a novel agonist of fatty acid receptor GPR40. Phytother. Res. 2010, 24, 1260-1263. [CrossRef]
21. Carullo, G.; Perri, M.; Manetti, F.; Aiello, F.; Caroleo, M.C.; Cione, E. Quercetin-3-oleoyl derivatives as new GPR40 agonists: Molecular docking studies and functional evaluation. Bioorg. Med. Chem. Lett. 2019, 29, 1761-1764. [CrossRef]
22. Clark, S.A.; Quaade, C.; Constandy, H.; Hansen, P.; Halban, P.; Ferber, S.; Newgard, C.B.; Normington, K. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 1997, 46, 958. [CrossRef]
23. Miyase, T.; Ueno, A.; Takizawa, N.; Kobayashi, H.; Oguchi, H. Ionone and lignan glycosides from Epimedium diphyllum. Phytochemistry 1989, 28, 3483-3485. [CrossRef]
24. Ma, S.J.; Mizutani, M.; Hiratake, J.; Sakata, K. Substrate specificity of β-primeverosidase, A key enzyme in aroma formation during oolong tea and black tea manufacturing. Biosci. Biotech. Bioch. 2001, 65, 2719-2729. [CrossRef] [PubMed]
25. Bisset, N.G.; Choudhury, A.K.; Houghton, P.J. Phenolic glycosides from the fruit of strychnos nux-vomica. Phytochemistry 1989, 28, 1553-1554. [CrossRef]
26. Saimaru, H.; Orihara, Y. Biosynthesis of acteoside in cultured cells of olea europaea. J. Nat. Med. 2010, 64, 139-145. [CrossRef]
27. Owen, R.W.; Mier, W.; Giacosa, A.; Hull, W.E.; Spiegelhalder, B.; Bartsch, H. Identification of lignans as major components in the phenolic fraction of olive oil. Clin. Chem. 2000, 46, 976.
28. Severina, P.; Brigida, D.A.; Monica, S.; Grazia, D.A.; Marialuisa, G.; Silvia, G.; Pietro, M.; Antonio, F. NMR-based metabolic profiling and in vitro antioxidant and hepatotoxic assessment of partially purified fractions from Golden germander (Teucrium polium L.) methanolic extract. J. Food Chem. 2012, 135, 1957-1967.
29. Smith, D.A.; Di, L.; Kerns, E.H. The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery. Nat. Rev. Drug Discov. 2010, 9, 929-939. [CrossRef]
30. Kujawski, J.; Popielarska, H.; Myka, A.; Drabińska, B.; Bernard, M.K. The log P parameter as a molecular descriptor in the computer-aided drug design-An overview. CMST 2012, 18, 81-88. [CrossRef]
31. Szumilak, M.; Galdyszynska, M.; Dominska, K.; Bak, S., II; Merecz-Sadowska, A.; Stanczak, A.; Karwowski, B.T.; Piastowska-Ciesielska, A.W. Synthesis, biological activity and preliminary in Silico ADMET screening of polyamine conjugates with bicyclic systems. Molecules 2017, 22, 794. [CrossRef]
32. Xiong, W.T.; Gu, L.; Wang, C.; Sun, H.X.; Liu, X. Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice. J. Ethnopharmacol. 2013, 150, 935-945. [CrossRef]
33. +-channel activity. Metabolism 2000, 49, 208-214. [CrossRef]
34. Jeppesen, P.B.; Gregersen, S.; Alstrup, K.K.; Hermansen, K. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: Studies in the diabetic Goto-Kakizaki (GK) rats. Phytomedicine 2002, 9, 9-14. [CrossRef] [PubMed]
35. Babujanarthanam, R.; Kavitha, P.; Pandian, M.R. Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fund Clin. Pharmacol. 2010, 24, 357-364. [CrossRef] [PubMed]
36. Jiang, H. Research on Manufacture Process, Chemical Constitude and Quality Control Method of Stevia rebaudianum Bertoni Effective Fraction. Master's Thesis, Beijing University of Chinese Medicine, Beijing, China, 2007.
37. Bhhatarai, B.; Wilson, D.M.; Parks, A.K.; Carney, E.W.; Spencer, P.J. Evaluation of TOPKAT, toxtree, and derek nexus in silico models for ocular irritation and development of a knowledge-based framework to improve the prediction of severe irritation. Chem. Res. Toxicol. 2016, 29, 810-822. [CrossRef] [PubMed]
38. Karunagaran, S.; Subhashchandrabose, S.; Lee, K.W.; Meganathan, C. Investigation on the isoform selectivity of novel kinesin-like protein 1 (KIF11) inhibitor using chemical feature based pharmacophore, molecular docking, and quantum mechanical studies. Comput. Biol. Chem. 2016, 61, 47-61. [CrossRef] [PubMed]
39. Thiyagarajan, V.; Lin, S.H.; Chang, Y.C.; Weng, C.F. Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking. Biomed. Pharm. 2016, 80, 52-62. [CrossRef]
40. Zhu, S.; Larkin, D.; Lu, S.; Inouye, C.; Haataja, L.; Anjum, A.; Kennedy, R.; Castle, D.; Arvan, P. Monitoring C-peptide storage and secretion in islet beta-cells in vitro and in vivo. Diabetes 2016, 65, 699-709. [CrossRef]